Stocks
News
ETFs
Economy
Currencies
Press Releases
Spyre Therapeutics, Inc. - Common Stock (SYRE)
Last Price
18.91
Change
+0.00 (0.00%)
NASDAQ
· Last Trade: Oct 14th, 5:38 AM EDT
Quote
News
Press Releases
Chart
Historical
FAQ
About
Competitors
12 Health Care Stocks Moving In Friday's After-Market Session
benzinga.com
Via
Benzinga
· October 10, 2025
This United Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
benzinga.com
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
Via
Benzinga
· September 26, 2025
Spyre (SYRE) Q2 R&D Up 23% Loss Narrows
fool.com
Via
The Motley Fool
· August 6, 2025
This Weyerhaeuser Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
benzinga.com
Via
Benzinga
· April 8, 2025
SYRE Stock Earnings: Spyre Therapeutics Beats EPS for Q2 2024
investorplace.com
SYRE stock results show that Spyre Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
· August 7, 2024
SYRE Stock Earnings: Spyre Therapeutics Misses EPS for Q1 2024
investorplace.com
SYRE stock results show that Spyre Therapeutics missed analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
· May 9, 2024
NIO Reports Upbeat Earnings, Joins Dave, V2X, Riskified And Other Big Stocks Moving Higher On Tuesday
benzinga.com
U.S. stocks were lower, with the Dow Jones index falling more than 200 points on Tuesday.
Via
Benzinga
· March 5, 2024
